Recent advances in the immunotherapy field require evaluation of the immune function to adapt 36 therapeutic decisions. Immune functional assays (IFA) are able to reveal the immune status and 37 would be useful to further adapt/improve patient's care. However, standardized methods are 38 needed to implement IFA in clinical settings. We carried out an independent validation of a 39 published method used to characterize the underlying host response to infectious conditions 40 using an IFA. We evaluate the reproducibility and robustness of this IFA and associated readout 41 using an independent healthy volunteers (HV) cohort. Expression of a 44 genes-signatures and 42 IFNγ protein secretion and gene-expression was assessed after stimulation. We observed a 43 strong host-response correlation between the two cohorts. We also highlight that standardized 44 methods for immune function evaluation exist and could be implemented in larger-scale studies. 45 This IFA could be a relevant tool to reveal innate/adaptive immune dysfunction in immune-46 related disorders patients. 47 Words count : 148 48 173
Introduction

50
The increase in patients suffering from immune-related disorders led to the 51 improvement in precise knowledge concerning the components and function of the immune 52 system. Whether of physiological or pathophysiological origin, i.e. immunosenescence [1] or 53 autoimmune diseases [2, 3] , the identification of immune alterations requires close monitoring 54 of the immune status. Their ever-increasing number and severity make these disorders a major 55 public health problem. Several therapies targeting the immune system, such as anti-56 inflammatory agents or immune stimulatory therapy, are currently used to re-balance the 57 immune system in immunocompromised patients. Nevertheless, clinicians lack the tools to 58 decipher immune status, and more precisely, immune function, in order to adapt therapeutic 59 decisions and personalize patient care. 60 In some clinical situations, the use of immune functional assays (IFAs) could help improve 61 management and reveal valuable information compared to the use of circulating biomarkers 62 such as cell counting or measurement of soluble and cell surface biomarkers. Based on the 63 evaluation of the immune response after an in vitro stimulation with antigen, IFAs allow 64 assessing the immune function as well as anticipate the ability to respond to therapy or fight a 65 pathogen. In the last few years, T-cell mediated immunity (blood-based) assays, such as 66 interferon gamma release assays (IGRA), have been developed and have revolutionized the 67 detection of latent tuberculosis infection (LTI). This type of test enables clinicians to be more 68 accurate and effective in the management of patients suffering from immune-related disorders.
69
Research, as well as clinical studies, use and adapt these IFAs to try to respond to specific 70 questions, such as the capacity of specific patients to respond to vaccination [4 -6]. Despite 71 encouraging results, the main challenge complicating the implementation of IFAs in clinical 72 settings is the need for standardization in order to perform these methods in any laboratory, in 73 a reliable and reproducible way [7] . 74 Such tests should minimize the number of steps during sample preparation and ideally use the 75 biological matrix directly sampled from the patient to limit technical variability and eliminate 76 the pre-analytical error. As already described for cytokine release assay [8, 9] , use of direct 77 measurement in whole blood sampling would be the relevant solution to minimize the risk of Interferon gamma (IFN-γ) release was quantified from Truculture's supernatant using 116 an immunoassay in the VIDAS ® platform (bioMérieux, Marcy l'Etoile, France).
117
As previously described, RNA extraction was performed using a modified protocol of the 118 NucleoSpin 96 RNA tissue kit (Macherey-Nagel Gmbh&Co. KG, Düren, Germany) and using 119 a vacuum system [12] . Nanostring technology was used for mRNA detection of a 44 gene panel 120 (details in supplementary table S1), an hybridization-based multiplex assay characterised by its 121 amplification-free step; 300 ng of RNA were hybridized to the probes at 67°C for 18 hours using a thermocycler (Biometra, Tprofesssional TRIO, Analytik Jena AG, Jena, Germany). Immune response after stimulation with SEB ( Fig. 1A) or LPS (Fig. 1C ) showed a 141 strong correlation between the two independent cohorts for the 44-gene expression signature, 142 confirmed by Deming regression on medians (Spearman's correlation coefficient rho= 0.99 for 143 SEB and 0.90 for LPS; Fig. 1B and 1D ) and on inter-deciles (Spearman's correlation coefficient 144 rho=0,96 for SEB and 0,94 for LPS; details in supplementary figure S1). In a second time, following SEB stimulation, a comparison of ifn-γ gene expression (in 150 the corresponding TruCulture) and IFN-γ release in the supernatant (Fig. 2) was performed. The In this study, we carried out an independent validation of a published method used to 159 characterize the underlying host response to infectious conditions using an IFA. We evaluate 160 the reproducibility and robustness of this IFA and associated readout using an independent 161 healthy volunteers (HV) cohort.
162
The strong host-response correlation between the two cohorts highlights that standardized 163 methods for immune function evaluation exist and could be implemented in larger-scale studies. 
